4
Changes in Ownership
ARDELYX, INC. Filed Acc 0001628280-25-041339
Chief Patient Officer sold 80,000 shares at $6.12 ($489,680)
- Chief Patient Officer acquired 50,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Williams Laura A Chief Patient Officer | 2025-08-26 | Option exercise 10b5-1 | +50,000 | $0.99 | $49,500 | 446,322 | D |
| Williams Laura A Chief Patient Officer | 2025-08-26 | Sale 10b5-1 | −50,000 | $6.12 | $306,050 | 396,322 | D |
| Williams Laura A Chief Patient Officer | 2025-08-26 | Sale 10b5-1 | −30,000 | $6.12 | $183,630 | 366,322 | D |
| Derivatives | |||||||
| Williams Laura A Chief Patient Officer | 2025-08-26 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −50,000 | 112,000 | D | ||
| Open-market sales · 80,000 sh · avg $6.12 · $489,680 | |||||||
Loading xslF345X05/wk-form4_1756423821.xml…